{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:50:10Z","timestamp":1793710210217,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.taap.2024.117066","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T07:01:00Z","timestamp":1723186860000},"page":"117066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Nicotinamide riboside activates SIRT3 to prevent paclitaxel-induced peripheral neuropathy"],"prefix":"10.1016","volume":"491","author":[{"given":"Xiaohan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2024.117066_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.taap.2024.117066_bb0015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.apsb.2021.06.014","article-title":"Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease","volume":"12","author":"Austad","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.taap.2024.117066_bb0025","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/brain\/awab184","article-title":"Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy","volume":"144","author":"Bosanac","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.taap.2024.117066_bb0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamaoncol.2018.6771","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"5","author":"Brown","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.taap.2024.117066_bb0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.freeradbiomed.2013.09.015","article-title":"Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs","volume":"65","author":"Butturini","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2024.117066_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"key":"10.1016\/j.taap.2024.117066_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.taap.2024.117066_bb0050","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.taap.2024.117066_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2024.117066_bb0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/jamainternmed.2022.1812","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"182","author":"Desai","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.taap.2024.117066_bb0065","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000939","article-title":"Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons","volume":"158","author":"Duggett","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.taap.2024.117066_bb0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.taap.2024.117066_bb0075","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2024.117066_bb0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.15585\/mmwr.mm6449a1","article-title":"Invasive Cancer Incidence and Survival--United States, 2012","volume":"64","author":"Henley","year":"2015","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.taap.2024.117066_bb2015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41418-020-00664-0","article-title":"ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation","volume":"28","author":"Pillai","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2024.117066_bb0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1570159X15666170915143217","article-title":"Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms","volume":"17","author":"Hu","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.taap.2024.117066_bb0090","first-page":"4413","article-title":"Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy","volume":"31","author":"Koskinen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2024.117066_bb0095","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ccell.2019.05.002","article-title":"Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis","volume":"35","author":"Li","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2024.117066_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.6004\/jnccn.2022.7074","article-title":"Patient-reported outcome measures in chemotherapy-induced peripheral neurotoxicity: defining minimal and clinically important changes","volume":"21","author":"Li","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.taap.2024.117066_bb0105","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0110","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2018.79.2721","article-title":"Integrative therapies during and after breast Cancer treatment: ASCO endorsement of the SIO clinical practice guideline","volume":"36","author":"Lyman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current Cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.taap.2024.117066_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103583","article-title":"Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders","volume":"28","author":"Mishra","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2024.117066_bb0125","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/antiox12101849","article-title":"Nicotinamide riboside and Phycocyanin oligopeptides affect stress susceptibility in chronic corticosterone-exposed rats","volume":"12","author":"Orhan","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.taap.2024.117066_bb2020","doi-asserted-by":"crossref","first-page":"871560","DOI":"10.3389\/fphar.2022.871560","article-title":"The double-edged sword of SIRT3 in cancer and its therapeutic applications","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2024.117066_bb0130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from Cancer or Cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0135","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1245\/s10434-020-09373-x","article-title":"SIRT3-mediated SOD2 and PGC-1\u03b1 contribute to Chemoresistance in colorectal Cancer cells","volume":"28","author":"Paku","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/cvr\/cvq250","article-title":"Mitochondrial SIRT3 and heart disease","volume":"88","author":"Pillai","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2024.117066_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.taap.2024.117066_bb0155","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1101\/gad.1527307","article-title":"SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress","volume":"21","author":"Scher","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2024.117066_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2011.03.001","article-title":"SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF","volume":"19","author":"Schumacker","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2024.117066_bb2000","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.taap.2024.117066_bb0165","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.taap.2024.117066_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919840098","article-title":"Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain","volume":"15","author":"Shim","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.taap.2024.117066_bb0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2024.117066_bb2010","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Alliance for Clinical Trials in Oncology, 2013. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2024.117066_bb2005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: A current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.taap.2024.117066_bb0180","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.molcel.2010.12.013","article-title":"Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress","volume":"40","author":"Tao","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2024.117066_bb0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cancers9070090","article-title":"SIRT3: oncogene and tumor suppressor in Cancer","volume":"9","author":"Torrens-Mas","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2024.117066_bb0190","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/ALN.0000000000000176","article-title":"Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy","volume":"120","author":"Zhang","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.taap.2024.117066_bb0195","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.7150\/thno.45922","article-title":"Mitochondrial Sirtuin 3: new emerging biological function and therapeutic target","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.taap.2024.117066_bb0200","article-title":"The role and therapeutic perspectives of Sirtuin 3 in Cancer metabolism reprogramming, metastasis, and Chemoresistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2024.117066_bb0205","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3390\/cells11162596","article-title":"The role of SIRT3 in exercise and aging","volume":"11","author":"Zhou","year":"2022","journal-title":"Cells"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:26:06Z","timestamp":1725855966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"alternative-id":["S0041008X24002643"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117066","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide riboside activates SIRT3 to prevent paclitaxel-induced peripheral neuropathy","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117066"}}